Similar shares of those with employer-sponsored coverage are potentially eligible for a GLP-1 antagonist as private coverage overall
Lilly will continue to pursue legal remedies against those who falsely claim their products are Mounjaro, Zepbound, or FDA-approved tirzepatide, including certain med-spas, wellness centers, online retailers, and compounding pharmacies. Simply put, the Big Pharma lobby is strong, the lawyers are ready and waiting, and were talking about the most commercialize-able drug in history
All pricing is subject to change
This product is not intended to diagnose, treat, cure, or prevent any disease." That language is present and confirms the product's status as a dietary supplement under DSHEA - not a pharmaceutical